Andrew Ambrosy, MD

Start Year
2014

Education and Training

Fellowship
Cardiovascular Disease, Duke University

Residency
Stanford Hospital and Clinics

Medical School
Northwestern University Feinberg School of Medicine

College/university
Georgetown University

Career and Research Goals

I am currently a general cardiology fellow. My goal is to pursue a career in academic cardiology focused on outcomes and clinical trials in acute and chronic heart failure.

Publications

Ambrosy, AP, Vaduganathan, M, Mentz, RJ, Greene, SJ, Subačius, H, Konstam, MA, Maggioni, AP, Swedberg, K, and Gheorghiade, M. "Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial." American heart journal 165, no. 2 (February 2013): 216-225.

PMID
23351825
Full Text

Vaduganathan, M, Greene, SJ, Ambrosy, AP, Gheorghiade, M, and Butler, J. "The disconnect between phase II and phase III trials of drugs for heart failure." Nature reviews. Cardiology 10, no. 2 (February 2013): 85-97. (Review)

PMID
23296069
Full Text

Butler, J, Subacius, H, Vaduganathan, M, Fonarow, GC, Ambrosy, AP, Konstam, MA, Maggioni, A, Mentz, RJ, Swedberg, K, Zannad, F, Gheorghiade, M, and EVEREST Investigators, . "Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial." Journal of the American College of Cardiology 61, no. 5 (February 2013): 571-579.

PMID
23246389
Full Text

Mentz, RJ, Allen, BD, Kwasny, MJ, Konstam, MA, Udelson, JE, Ambrosy, AP, Fought, AJ, Vaduganathan, M, O'Connor, CM, Zannad, F, Maggioni, AP, Swedberg, K, Bonow, RO, and Gheorghiade, M. "Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial." Eur J Heart Fail 15, no. 1 (January 2013): 61-68.

PMID
22968743
Full Text

Lanfear, DE, Sabbah, HN, Goldsmith, SR, Greene, SJ, Ambrosy, AP, Fought, AJ, Kwasny, MJ, Swedberg, K, Yancy, CW, Konstam, MA, Maggioni, AP, Zannad, F, Gheorghiade, M, and EVEREST trial investigators, . "Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial." Circulation. Heart failure 6, no. 1 (January 2013): 47-52.

PMID
23239836
Full Text

Ambrosy, AP, Kunz, PL, Fisher, GA, and Witteles, RM. "Capecitabine-induced chest pain relieved by diltiazem." The American journal of cardiology 110, no. 11 (December 2012): 1623-1626.

PMID
22939579
Full Text

Mentz, RJ, Chung, MJ, Gheorghiade, M, Pang, PS, Kwasny, MJ, Ambrosy, AP, Vaduganathan, M, O'Connor, CM, Swedberg, K, Zannad, F, Konstam, MA, and Maggioni, AP. "Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial." Am Heart J 164, no. 6 (December 2012): 884-92.e2.

PMID
23194489
Full Text

Vaduganathan, M, Ambrosy, AP, Greene, SJ, Mentz, RJ, Subacius, HP, Maggioni, AP, Swedberg, K, Nodari, S, Zannad, F, Konstam, MA, Butler, J, Gheorghiade, M, and EVEREST trial investigators, . "Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial." Circulation. Heart failure 5, no. 6 (November 2012): 750-758.

PMID
23051949
Full Text

Mentz, RJ, Schmidt, PH, Kwasny, MJ, Ambrosy, AP, O'Connor, CM, Konstam, MA, Zannad, F, Maggioni, AP, Swedberg, K, and Gheorghiade, M. "The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial." J Card Fail 18, no. 7 (July 2012): 515-523.

PMID
22748484
Full Text

Ambrosy, AP, Fonarow, GC, Albert, NM, Curtis, AB, Heywood, JT, Mehra, MR, O'Connor, CM, Reynolds, D, Walsh, MN, Yancy, CW, and Gheorghiade, M. "B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF." J Cardiovasc Med (Hagerstown) 13, no. 6 (June 2012): 360-367.

PMID
22472850
Full Text

Pages